HONG KONG – In a final ruling, the U.K.'s High Court of Justice ruled in favor of Tokyo-based Fujifilm Kyowa Kirin Biologics Co. Ltd. in a patent revocation proceeding against Abbvie Inc., which has been fighting to protect its blockbuster Humira (adalimumab).
HONG KONG – In a final ruling, the U.K.'s High Court of Justice ruled in favor of Tokyo-based Fujifilm Kyowa Kirin Biologics Co. Ltd. in a patent revocation proceeding against Abbvie Inc., which has been fighting to protect its blockbuster Humira (adalimumab).
HONG KONG – It is a tumultuous year for Korean conglomerate Samsung, whose group chief Jay Y. Lee was arrested Friday in connection to a corruption scandal, and Samsung Biologics Co. Ltd., the company's contract manufacturer arm of biologic drugs, coming under scrutiny with allegations of being involved in unlawful accounting practices.
HONG KONG – It is a tumultuous year for Korean conglomerate Samsung, whose group chief Jay Y. Lee was arrested Friday in connection to a corruption scandal, and Samsung Biologics Co. Ltd., the company's contract manufacturer arm of biologic drugs, coming under scrutiny with allegations of being involved in unlawful accounting practices.
HONG KONG – It is not surprising that Tokyo-based Kyowa Hakko Kirin Co. Ltd. wants to hold on to Nesp (darbepoetin alfa), an erythropoiesis-stimulating agent used as a treatment for improving renal anemia, when the patent expires in 2019.
